Imaging in oncology is a fundamental component of cancer diagnosis, staging, treatment planning, and monitoring for response to therapy. The session "Oncology Imaging" is dedicated to the most recent developments, technologies, and applications that promote accuracy and patient care in oncology.".
Current imaging modalities, such as CT, MRI, PET, and molecular imaging, enable clinicians to depict tumors accurately, measure their size and location, and determine their metabolic activity, as well as identify metastases. These modalities yield critical information for choosing appropriate treatment methods and following therapy response during a period of time. New modalities, like functional imaging and hybrid methods, enhance the capacity for real-time evaluation of tumor biology and microenvironment further.
The session also discusses the marriage of imaging with machine learning and artificial intelligence, which enhances image analysis, identifies subtle changes, and more precisely forecasts outcomes. Imaging biomarkers may inform personalized treatment choices, track minimal residual disease, and assist in the prediction of therapeutic resistance.
Attendees will learn about state-of-the-art imaging practice, technological advances, and their clinical application in oncology. This session highlights the value of advanced imaging in early detection, accurate treatment planning, and continuous monitoring, ultimately leading to better patient outcomes and quality of care in cancer management.
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
